Literature DB >> 10965635

Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.

M E Franklin1, J S Abramowitz, M J Kozak, J T Levitt, E B Foa.   

Abstract

The efficacy of exposure and ritual prevention (EX/RP) for reducing symptoms of obsessive-compulsive disorder (OCD) has been demonstrated in several randomized controlled trials (RCTs). However, procedures used in these studies to maximize experimental control may have limited their generalizability to typical clinical practice. Treatment outcome data from 110 clinical patients receiving EX/RP on an outpatient fee-for-service basis were compared with findings from 4 RCTs of EX/RP. Adult patients in the clinical sample were not excluded because of treatment history, concomitant pharmacotherapy, psychiatric comorbidity, age, or OCD severity. Clinical patients achieved substantial and clinically meaningful reductions in their OCD and depressive symptoms following EX/RP, which were comparable with those reported in the RCTs. Findings indicate that EX/RP is a potent treatment for OCD, and its benefits are not limited to select patient samples.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965635

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  34 in total

1.  Treatment of Sexual-Orientation Obsessions in Obsessive-Compulsive Disorder Using Exposure and Ritual Prevention.

Authors:  Monnica T Williams; Marjorie Crozier; Mark Powers
Journal:  Clin Case Stud       Date:  2011-02

2.  Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.

Authors:  Martin E Franklin; Jeffrey Sapyta; Jennifer B Freeman; Muniya Khanna; Scott Compton; Daniel Almirall; Phoebe Moore; Molly Choate-Summers; Abbe Garcia; Aubrey L Edson; Edna B Foa; John S March
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

3.  Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.

Authors:  Timothy B Baker; Richard M McFall; Varda Shoham
Journal:  Psychol Sci Public Interest       Date:  2008-11-01

Review 4.  Psychotherapy for obsessive-compulsive disorder.

Authors:  Eric A Storch; Amy Mariaskin; Tanya K Murphy
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

5.  Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?

Authors:  Michael G Wheaton; David Rosenfield; Edna B Foa; H Blair Simpson
Journal:  J Consult Clin Psychol       Date:  2015-05-25

6.  Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial.

Authors:  Jennifer Freeman; Jeffrey Sapyta; Abbe Garcia; Scott Compton; Muniya Khanna; Chris Flessner; David FitzGerald; Christian Mauro; Rebecca Dingfelder; Kristen Benito; Julie Harrison; John Curry; Edna Foa; John March; Phoebe Moore; Martin Franklin
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596

7.  Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well?

Authors:  Michael G Wheaton; Hanga Galfalvy; Shari A Steinman; Melanie M Wall; Edna B Foa; H Blair Simpson
Journal:  Behav Res Ther       Date:  2016-07-29

8.  A Non-randomized Comparison of Strategies for Consultation in a Community-Academic Training Program to Implement an Evidence-Based Psychotherapy.

Authors:  Shannon Wiltsey Stirman; Kristin Pontoski; Torrey Creed; Regina Xhezo; Arthur C Evans; Aaron T Beck; Paul Crits-Christoph
Journal:  Adm Policy Ment Health       Date:  2017-01

Review 9.  Symptom dimensions in obsessive-compulsive disorder: phenomenology and treatment outcomes with exposure and ritual prevention.

Authors:  Monnica T Williams; Beth Mugno; Martin Franklin; Sonya Faber
Journal:  Psychopathology       Date:  2013-04-20       Impact factor: 1.944

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.